Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

308 studies match

clinicaltrialsPublishedShowing 151–200 of 308 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06036836	Study of Favezelimab Coformulated With Pembrolizumab (MK-4280A) in Participants With Selected Solid Tumors (MK-4280A-010)	completed	Phase 2	163	Merck Sharp & Dohme LLCINDUSTRY	10	Mar 19, 2026	clinicaltrials
NCT02952508	Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom(CLOVER-WaM)	active not recruiting	Phase 2	120	Cellectar Biosciences, Inc.INDUSTRY	11	Mar 18, 2026